ANI파마슈티컬스 (ANIP) 주가

ANI파마슈티컬스(ANIP)는 NASDAQ에 상장된 Healthcare · Drug Manufacturers - Specialty & Generic 기업입니다. 현재가 $76.14 (+0.99%), 시가총액 $1.83B, PER (주가수익비율) 20.54, 52주 최저~최고 $57.27 ~ $98.81.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baude

핵심 지표

• 현재가: $76.14 (+0.99%)
• 시가총액: $1.83B
• PER (주가수익비율): 20.54
• 52주 최저~최고: $57.27 ~ $98.81
• 섹터: Healthcare
• 산업: Drug Manufacturers - Specialty & Generic
• 거래소: NASDAQ

ANI파마슈티컬스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

ANI파마슈티컬스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.3333

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 3.15
• 순이익률: 0.10%
• 영업이익률: 0.16%

자주 묻는 질문